Literature DB >> 17414886

In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.

Myriam Wartski1, Elise Le Stanc, Eric Gontier, Didier Vilain, Alain Banal, Catherine Tainturier, Alain Paul Pecking, Jean Louis Alberini.   

Abstract

OBJECTIVES: In patients with cervical lymph node metastases from unknown primary tumour (UPT), the primary tumour is frequently localized in the head and neck area. Because the detection of the primary tumour is of importance to optimize the patient's management and allows a targeted therapy, the performances of hybrid positron emission tomography-computed tomography (PET-CT) using fluorodeoxyglucose (FDG) were evaluated in a retrospective study.
METHODS: Thirty-eight consecutive patients with cervical lymph node metastases, and in whom the primary was not detected by the comprehensive diagnostic work-up including endoscopy and conventional imaging methods, were referred for a PET-CT scan.
RESULTS: PET-CT was positive with an increased FDG focal uptake suggesting the potential primary site in 68% of patients (26/38), which guided the biopsies during a second rigid panendoscopy in 17 of these 26 patients: 13 primary tumours were then histologically proven. PET-CT showed distant lesions in three patients. It had treatment-related implications in 23/38 patients (60%), consisting of modification of radiation planning, surgery or abstention from surgery.
CONCLUSION: Hybrid FDG-PET-CT is helpful for the detection of a potential head and neck primary tumour. Furthermore, hybrid FDG-PET-CT has the ability to diagnose occult or distant second tumour and metastatic disease and modify patient management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17414886     DOI: 10.1097/MNM.0b013e3280708edf

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  15 in total

Review 1.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

2.  Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.

Authors:  Kenichiro Yabuki; Mamoru Tsukuda; Choichi Horiuchi; Takahide Taguchi; Goshi Nishimura
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-03       Impact factor: 2.503

3.  Management of lymph node metastases from an unknown primary site to the head and neck (Review).

Authors:  Shi Min Zhuang; Xi-Fu Wu; Jing-Jia Li; Ge-Hua Zhang
Journal:  Mol Clin Oncol       Date:  2014-07-29

4.  Cervical lymphadenopathy: study of 251 patients.

Authors:  Basel Al Kadah; Hristo Hristov Popov; Bernhard Schick; Dirk Knöbber
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-08       Impact factor: 2.503

5.  Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma.

Authors:  Masahiro Kikuchi; Shogo Shinohara; Yuji Nakamoto; Yu Usami; Keizo Fujiwara; Tsunemichi Adachi; Shin-ya Hori; Yosuke Tona; Hiroshi Yamazaki; Yukihiro Imai; Yasushi Naito
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

6.  Impact of 18F-Fluorodeoxyglucose positron emission tomography on management of cancer of unknown primary: systematic review and meta-analysis.

Authors:  Sungmin Woo; Anton S Becker; Richard K G Do; Heiko Schöder; Hedvig Hricak; H Alberto Vargas
Journal:  Eur J Cancer       Date:  2021-11-02       Impact factor: 9.162

Review 7.  Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP.

Authors:  Nicholas Pavlidis; George Pentheroudakis; George Plataniotis
Journal:  Clin Transl Oncol       Date:  2009-06       Impact factor: 3.405

Review 8.  FDG PET/CT in carcinoma of unknown primary.

Authors:  Thomas C Kwee; Sandip Basu; Gang Cheng; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

9.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

10.  Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases.

Authors:  Inanç Karapolat; Kamil Kumanlıoğlu
Journal:  Mol Imaging Radionucl Ther       Date:  2012-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.